CLINICS 2011;66(2):321-325 11. Deak F, Lasztoczi B, Pacher P, Petheo¨ GL, Kecskemeti V, Spa¨t A. Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology. 2000;39:1029–36. 12. Ni YG, Miledi R. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA. 1997;94:2036–49. 13. Fan P. Effects of antidepressants on the inward current mediated by 5- HT3 receptors in rat nodose ganglion neuron. Br J Pharmacol. 1994;112: 741–4. 14. Maggi L, Palma E, Miledi R, Eusebi F. Effects of fluoxetine on wild and mutant neuronal a7 nicotinic receptors. Mol Psychiatry. 1998;3:350–5. 15. Galeotti N, Ghelardini C, Bartolini A. Involvement of potassium channels in amitriptyline and clomipramine analgesia. Neuropharma- cology. 2001;40:75–84. 16. DeFelipe MC, De Ceballos ML, Gil C, Fuentes JA. Chronic antidepressant treatment increases enkephalin levels in nucleus accumbens and striatum of the rat. Eur J Pharmacol. 1985;112:119-22. 17. Gray AM, Spencer PSJ, Sewell RDE. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br J Pharmacol. 1998;124:669-74. 18. Hwang J, Zheng LT, Ock J, Lee MG, Kim SH, Lee HW. et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepres- sants. Neuropharmacology. 2008;55:826–34. 19. Mao QX, Yang TD. Amitriptyline upregulates EAAT1 and EAAT2 in neuropathic pain rats. Brain Res Bull. 2010;81:424–7. 20. Sernagor E, Kuhn D, Vyklicky JrL, Mayer ML. Open channel block of NMDA receptor responses evoked by tricyclic antidepressants. Neuron. 1989;2:1221–7. 21. Ocana MA, Cendan CM, Cobos EJ, Entrena JM, Baeyens JM. Potassium channels and pain: present realities and future opportunities. Eur J Pharmacol. 2004;500:203–19. 22. Welch SP, Dunlow LD. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists, a common mechanism of action? J Pharmacol Exp Ther. 1993;267:390–9. Effect of glibenclamide on antinociceptive effects of antidepressants Hajhashemi V and Amin B 23. Galeotti N, Ghelardini C, Bartolini A. The role of potassium channels in antihistamine analgesia. Neuropharmacology. 1990;38:1893–901. 24. Galeotti N, Ghelardini C, Capaccioli S, Quattrone A, Nicolin A, Bartolini A. Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel. Eur J Pharmacol. 1997;330:15-25. 25. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977;4:161–74. 26. Woolf CJ. Moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med. 2004;140:441–51. 27. Casis O, Gallego M, Sa´nchez-Chapula JA. Imipramine, mianserine and maprotiline block delayed rectifier potassium current in ventricular myocytes. Pharmacol Res. 2002;45:141-6. 28. Bobker DH, Williams JT. Ion conductance affected by 5-HT receptor subtypes in mammalian neurones. Trends Neurosci. 1990;13: 169–73. 29. Bardin L, Tarayre JP, Malfetes N, Koek W, Colpaert FC. Profound, non- opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain. Pharmacology. 2003;67:182–94. 30. Colpaert FC. 5-HT1A receptor activation: new molecular and neuroa- daptive mechanisms of pain relief. Curr Opin in Investig Drugs. 2006;7:40–7. 31. Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain. 2005;114:482–90. 32. Robles LI, Barrios M, Del Pozo E, Dordal A, Baeyens JM. Effects of K+ channel blockers and openers on antinociception induced by agonists of 5-HT1A receptors. Eur J Pharmacol. 1996;295:181–8. 325